|23.00||-1.41 / -5.78%|
As of 3:59pm ET
|23.00||0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 42.50, with a high estimate of 48.00 and a low estimate of 35.00. The median estimate represents a +84.78% increase from the last price of 23.00.
The current consensus among 5 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.